Reported Friday, AEON Biopharma Receives Additional NYSE American Non-Compliance Notice Over $4M Stockholders' Equity Requirement Amid $55M Stockholders' Deficit

Benzinga Newsdesk www.benzinga.com Positive 70.3%

Neg 0% Neu 0% Pos 70.3%

Comments

No comments yet. Be the first!